Summary:
- This article describes the development of a new gene therapy approach to treat a rare genetic disorder called Duchenne muscular dystrophy (DMD).
- The researchers used a modified virus to deliver a functional version of the dystrophin gene, which is defective in DMD patients, to muscle cells in mice.
- The gene therapy was able to restore dystrophin production and improve muscle function in the treated mice, suggesting it could be a promising treatment for DMD in the future.